Masaharu Hayashi
Overview
Explore the profile of Masaharu Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
1287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura H, Doi H, Miyaji Y, Wada T, Takahashi E, Tada M, et al.
BMC Neurol
. 2024 Sep;
24(1):310.
PMID: 39232641
Background: Pathogenic variants in Gap junction protein beta 1 (GJB1), which encodes Connexin 32, are known to cause X-linked Charcot-Marie-Tooth disease (CMTX), the second most common form of CMT. CMTX...
2.
Minamiyama Y, Takeda H, Hayashi M, Asaoka M, Yamaji K
PLoS One
. 2024 Apr;
19(4):e0301772.
PMID: 38662657
In recent years, with the trend of open science, there have been many efforts to share research data on the internet. To promote research data sharing, data curation is essential...
3.
Yoshimi K, Nakagawa K, Yamaguchi K, Nakane A, Hayashi M, Miyata R, et al.
Healthcare (Basel)
. 2023 Jun;
11(11).
PMID: 37297761
Factors influencing oral problems, such as malocclusion and oral motor dysfunction, in patients with prolonged disorders of consciousness (DOC) remain unclear. This study aimed to clarify the relationship between oral...
4.
Kimura K, Murase N, Nagao Y, Nozaki M, Fukumizu M, Kita Y, et al.
Brain Dev
. 2023 Mar;
45(6):324-331.
PMID: 36878743
Objective: Tourette syndrome (TS) is a neurobehavioral disorder characterized by motor and vocal tics. Simple tics are purposeless involuntary movements that spontaneously resolve during middle adolescence. Complex tics appear to...
5.
Inoue Y, Hamano S, Hayashi M, Sakuma H, Hirose S, Ishii A, et al.
Epileptic Disord
. 2022 Feb;
24(1):82-94.
PMID: 35118943
Objective: To examine the current medical and psychosocial status of patients with epilepsy, aiming to facilitate appropriate application of the Intractable/Rare Diseases Act of Japan. Methods: By analysing the cross-sectional...
6.
Yoshitomi S, Hamano S, Hayashi M, Sakuma H, Hirose S, Ishii A, et al.
Epileptic Disord
. 2021 Jul;
23(4):579-589.
PMID: 34269179
Objective: To unveil current medical and psychosocial conditions of patients with West syndrome in Japan. Methods: A cross-sectional analysis was performed in patients with West syndrome registered in the Rare...
7.
Hayashi M, Mishima K, Fukumizu M, Takahashi H, Ishikawa Y, Hamada I, et al.
J Autism Dev Disord
. 2021 Jun;
52(6):2784-2793.
PMID: 34181143
Robust clinical evidence has not been available for melatonin, a drug commonly administered for treating sleep problems of children with autism spectrum disorder (ASD). In a phase 3 randomized, placebo-controlled...
8.
Hoshino K, Sweadner K, Kawarai T, Saute J, Freitas J, Damasio J, et al.
Neurol Genet
. 2021 May;
7(2):e562.
PMID: 33977143
No abstract available.
9.
Hirota Y, Hayashi M, Miyauchi Y, Ishii Y, Tanaka Y, Fujimoto K
Biochem Biophys Res Commun
. 2021 Apr;
556:9-15.
PMID: 33836347
Lysosome-associated protein transmembrane 4α (LAPTM4α) is a four transmembrane-spanning protein primarily localized in endosomes and lysosomes and has several putative lysosomal targeting signals at its C-terminal cytoplasmic domain, including tyrosine-based...
10.
Hoshino K, Hayashi M, Ishizaki A, Kimura K, Kubota M, Nezu A, et al.
Front Pediatr
. 2021 Mar;
9:569594.
PMID: 33748036
Post-synaptic dopamine receptor supersensitivity (DARSS) has been extensively researched by Dr. Masaya Segawa, who has investigated the efficacy of very-low-dose levodopa therapy (VLDT; 0.5-1 mg/kg/day). Considerable Japanese research supports the...